glp-1 agonists and retained gastric contents at endoscopy Gastrointestinal effects of receptor agonists: mechanisms, management, future directions PDF) GLP-1 receptor agonist increase

identified protein phosphatase 6 (PP6) holoenzyme components as regulators of TAK1 inhibitor-induced PANoptosis by analyzing results from a cell death-based genome-wide CRISPR screen

Older people are more likely to have a deficiency because they might not absorb vitamin B12 as well as they used to

Tissue-Specific Research Evidence: Translating Mechanisms to Models Gastric Mucosa: The Original Model The gastric mucosal protection model is where BPC-157 research began and where the mechanistic evidence is deepest

The Promise and Challenges of Next-Gen Obesity Drugs The semaglutide drug Ozempic, developed by Novo Nordisk, is currently dominating the US market, but competition in the pharmaceutical industry is pushing for even more potent medications